Soluble endothelial adhesion molecules and inflammation markers in patients with β-thalassemia intermedia

Blood Cells, Molecules, and Diseases

Volumn 43, Issue 3, 2009, Pages 230-234

  Kanavaki, Ino ^a   Makrythanasis, Periklis ^a   Lazaropoulou, Christina ^a   Tsironi, Maria ^b   Kattamis, Antonis ^c   Rombos, Ioannis ^c   Papassotiriou, Ioannis ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF PELOPONNESE   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adhesion molecules; Endothelium; Inflammation; Thalassemia intermedia

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROXYUREA; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; BLOOD VESSEL INJURY; CHILD; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; GREECE; HUMAN; MALE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHOOL CHILD; SPLENECTOMY;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CHILD; ENDOTHELIUM; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 71749092657     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2009.06.002     Document Type: Article

References (19)

1. Camaschella C., and Cappellini M.D. Thalassemia intermedia. Haematologica 80 (1995) 58-68
2. Taher A., Isma'eel H., and Cappellini M.D. Thalassemia intermedia: revisited. Blood Cell. Mol. Dis. 37 (2006) 12-20
3. Aessopos A., Kati M., and Meletis J. Thalassemia intermedia today: should patients regularly receive transfusions?. Transfusion 47 (2007) 792-800
4. Taher A.T., Otrock Z.K., Uthman I., and Cappellini M.D. Thalassemia and hypercoagulability. Blood Rev. 22 (2008) 283-292
5. Eldor A., and Rachmilewitz E.A. The hypercoagulable state in thalassemia. Blood 99 (2002) 36-43
6. Karimi M., Khanlari M., and Rachmilewitz E.A. Cerebrovascular accident in beta-thalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI). Am. J. Hematol. 83 (2008) 77-79
7. Manfre L., Giarratano E., Maggio A., et al. MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. Am. J. Roentgenol. 173 (1999) 1477-1480
8. Cappellini M.D., Robbiolo L., Bottasso B.M., et al. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassemia intermedia. Br. J. Haematol. 111 (2000) 467-473
9. Aggeli C., Antoniades C., Cosma C., et al. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int. J. Cardiol. 105 (2005) 80-84
10. Archararit N., Chuncharunee S., Pornvoranunt A., et al. Serum C-reactive protein level in postsplenectomized thalassemic patients. J. Med. Assoc. Thai. 83 (2000) S63-69
11. Cappellini M.D. Coagulation in the pathophysiology of hemolytic anemias. Hematol. Am. Soc. Hematol. Educ. Prog. (2007) 74-78
12. Butthep P., Bunyaratvej A., Funahara Y., et al. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study. Southeast Asian J. Trop. Med. Public Health 28 (1997) 141-148A
13. Kyriakou D.S., Alexandrakis M.G., Kyriakou E.S., et al. Activated peripheral blood and endothelial cells in thalassemia patients. Ann. Hematol. 80 (2001) 577-583
14. Butthep P., Bunyaratvej A., Funahara Y., et al. Alterations in vascular endothelial cell-related plasma proteins in thalassaemic patients and their correlation with clinical symptoms. Thromb Haemost. 74 (1995) 1045-1049
15. Hovav T., Goldfarb A., Artmann G., Yedgar S., and Barshtein G. Enhanced adherence of beta-thalassaemic erythrocytes to endothelial cells. Br. J. Haematol. 106 (1999) 178-181
16. Aessopos A., Kati M., and Farmakis D. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. Haematologica 92 (2007) 658-665
17. Wu K.K., Aleksic N., Ballantyne C.M., et al. Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease. Circulation 107 (2003) 1729-1732
18. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
19. Verma S., Li S.H., Badiwala M.V., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105 (2002) 1890-1896